Treatment of patients with refractory diffuse large B-cell lymphoma or mantle cell lymphoma with alemtuzumab, alone or in combination with cytotoxic chemotherapy

MeSH terms

• Adult
• Aged
• Alemtuzumab
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Humanized
• Antibodies, Neoplasm / therapeutic use*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Drug Resistance, Neoplasm
• Female
• Humans
• Lymphoma, Large B-Cell, Diffuse / drug therapy*
• Lymphoma, Large B-Cell, Diffuse / pathology
• Lymphoma, Mantle-Cell / drug therapy*
• Lymphoma, Mantle-Cell / pathology
• Male
• Middle Aged
• Neoplasm Recurrence, Local / drug therapy*
• Neoplasm Recurrence, Local / pathology
• Pilot Projects
• Salvage Therapy
• Survival Rate
• Treatment Outcome
• Young Adult